MAIA Biotechnology Files 8-K: Material Agreement, Equity Sales
Ticker: MAIA · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1878313
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-event
Related Tickers: MAIA
TL;DR
MAIA Bio inked a big deal & sold stock, check the 8-K for deets.
AI Summary
MAIA Biotechnology, Inc. announced on February 24, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for MAIA Biotechnology, including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- February 24, 2025 (date) — Date of earliest event reported
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL 60606 (address) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by MAIA Biotechnology, Inc.?
The filing states that MAIA Biotechnology, Inc. entered into a material definitive agreement on February 24, 2025, but the specific details of this agreement are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 24, 2025.
What are the principal executive offices of MAIA Biotechnology, Inc.?
The principal executive offices of MAIA Biotechnology, Inc. are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What other types of events are reported in this 8-K filing besides the material agreement?
In addition to the material definitive agreement, the filing also reports on unregistered sales of equity securities and other events.
What is the filing date for this Current Report (Form 8-K)?
This Current Report (Form 8-K) was filed as of February 25, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding MAIA Biotechnology, Inc. (MAIA).